News & Perspective

Nov 21, 2012

Nov 21, 2012

FDA clears first cell-based flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the nation's first cell-based flu vaccine, a product from Novartis that uses technology that could help vaccinate more Americans in a pandemic but still has many of the same limitations of older egg-based flu vaccines.

Oct 15, 2012

Oct 15, 2012

Report: Complacency, misperception stymie quest for better flu vaccines

The world needs much better influenza vaccines, but the quest for them faces a formidable barrier: overconfidence about the effectiveness of existing influenza vaccines.

Sep 13, 2012

Sep 13, 2012

HHS renews contracts for pandemic vaccine activities

(CIDRAP News) – The US Department of Health and Human Services (HHS) recently awarded a new round of contracts to the five US-licensed influenza vaccine manufacturers to make pre-pandemic and pandemic influenza vaccines—projects that could be worth billions of dollars if another pandemic arises in the next few years.

May 11, 2012

May 11, 2012

IOM offers tools to help guide vaccine development

(CIDRAP News) – The Institute of Medicine (IOM) yesterday unveiled a decision-support model with a test version of software to help policymakers and other stakeholders determine what vaccines to develop at both national and global levels.

Feb 08, 2012

Feb 08, 2012

NVAC approves recommendations on health worker flu vaccination

(CIDRAP News) – An advisory group to the US Department of Health and Human Services (HHS) today approved a set of voluntary measures designed to boost flu vaccination in healthcare workers.

Feb 07, 2012

Feb 07, 2012

Federal advisors propose steps to boost health worker flu vaccination

(CIDRAP News) – Federal vaccine advisors today unveiled proposed voluntary recommendations for increasing flu vaccination in healthcare workers, sparking strong reactions from employee groups who object to language that stops just short of urging mandatory vaccination.

Jan 06, 2012

Jan 06, 2012

HHS orders novel H3N2 vaccine for clinical trials

(CIDRAP News) – The US Department of Health and Human Services (HHS) is taking steps to prepare for clinical trials of a vaccine targeted to a novel H3N2 influenza strain that has infected at least 12 people so far, in case one is needed, a department official said today.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»